Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
F2 Bioscience I 2017 Ltd
10% owner at Cullinan Therapeutics. Filing since 21 Jun 2022.
CIK 0001838573
Company
Date
Role
Action
Shares
Amount
Of holding
CGEM
Cullinan Therapeutics, Inc.
23 Jun 2022
10% owner
Sold, plan not stated
29,631
$385.31K
5.2%
CGEM
Cullinan Therapeutics, Inc.
22 Jun 2022
10% owner
Sold, plan not stated
49,953
$634.58K
8.1%
CGEM
Cullinan Therapeutics, Inc.
21 Jun 2022
10% owner
Sold, plan not stated
22,319
$284.93K
3.5%
3 decisions on file.
